pharmacovigilance Archives - Inspire Corporate

The real world online-Understanding and using patient-reported real world evidence from social media
Patient insights

The real world online-Understanding and using patient-reported real world evidence from social media

The real world online--Understanding and using patient-reported real world evidence from social media By Monica St Claire Next week, I will be presenting at the Patient Registries and Real World Evidence Summit in Miami. The focus of the conference is Real World Evidence (RWE) in drug development, FDA approval and payer reimbursement. Beginning with an overview of patient and caregiver activity on social media, my session will explore the use of content created by patients and caregivers on social media as RWE. From my experience as a sociolinguist and social media researcher, I’ve found that patients and [...]

Jan 2019By Monica St Claire|0 Comments

How R&D Teams Can Use Patient-Centricity for Clinical Trial Optimization
Clinical trials

How R&D Teams Can Use Patient-Centricity for Clinical Trial Optimization

How R&D Teams Can Use Patient Centricity for Clinical Trial Optimization By Monica St. Claire In 2014, Tufts Center for the Study of Drug Development performed a comprehensive assessment of the use of social media and digital technology in clinical research. This forward-thinking study revealed that pharmaceutical, biotechnology companies and contract research organizations (CROs) had not implemented strategies to effectively utilize and capitalize on the patient and caregiver content available.1 Today, Inspire’s products and services address these clinical trial optimization essentials. Specifically, our tools provide pharmaceutical and biotechnology companies’ research and development (R&D) teams as well [...]

Aug 2018By Monica St Claire|0 Comments

Inspire posts forward medical research in adverse drug reactions, new study shows
Patient engagement

Inspire posts forward medical research in adverse drug reactions, new study shows

Inspire posts forward medical research in adverse drug reactions, new study shows Over 2 million injuries, hospitalizations and deaths in the US each year are associated with post-approval adverse drug reactions (ADRs).1 The usual method of gathering ADR data is through provider reporting. Research suggests that health care providers tend to under-report ADRs, sometimes because patients just don’t discuss all of their treatment experiences with them.2 Supplementing spontaneous provider-reliant reporting could be extremely beneficial to patient safety. In Can Patient-Generated Health Communication on the Internet Enhance Pharmacovigilance? (Part 1)3 and Research Confirms: Valuable Patient-Centered Data on Inspire [...]

Mar 2018By Jeff Terkowitz|0 Comments

Research Confirms: Valuable Patient-Centered Data on Inspire (Part 2)
Patient engagement

Research Confirms: Valuable Patient-Centered Data on Inspire (Part 2)

Research Confirms: Valuable Patient-Centered Data on Inspire (Part 2) In part 1, Can Patient-Generated Health Communication on the Internet Enhance Pharmacovigilance?, I shared the results of a think tank co-sponsored by the Drug Information Association (DIA) and the Cardiac Safety Research Consortium discussing the use of patient postings on social media for pharmacovigilance. Today's post answers the question: Would Inspire’s patient-generated health discussions be useful for pharmacovigilance? Historically, pharmaceutical companies embraced a medication-focused approach to pharmacovigilance. Now, however, as R&D in the pharmaceutical industry is incorporating patient-centric methodologies in their processes, regulatory guidance is also transforming drug [...]

Oct 2017By Jeff Terkowitz|0 Comments

Can Patient-Generated Health Communication on the Internet Enhance Pharmacovigilance?
Patient engagement

Can Patient-Generated Health Communication on the Internet Enhance Pharmacovigilance?

Can Patient-Generated Health Communication on the Internet Enhance Pharmacovigilance? (Part 1) Spontaneous reporting of adverse drug reactions by health care providers has been the keystone of pharmacovigilance. Yet health care providers tend to under-report for a variety of reasons including lack of time, complacency, indifference, fear of medico-legal consequences or their uncertainty of the causal relationship between medication and condition.1 An unexpected opportunity to supplement spontaneous provider reliant reporting may be at hand. Communication about personal health that occurs over the Internet could be a resource for pharmacovigilance. In June 2016, a think tank co-sponsored by the [...]

Oct 2017By Jeff Terkowitz|0 Comments